MDNews - Cleveland-Akron-Canton

November/December 2015

Issue link: http://viewer.e-digitaledition.com/i/589857

Contents of this Issue

Navigation

Page 17 of 43

of these microspheres have been supplied worldwide since 2002, so it's not a brand new treatment. It's just not been available in Stark County until this year. Aultman is currently one of only a few cancer programs in Ohio offering SIRT." Patients eligible for SIRT may include those with: + Colorectal cancer with unresectable liver metastases + Bilirubin of less than two + Less than 60 percent tumor involvement + ECOG performance score less than two Chemoembolization Like SIRT, chemoembolization is also indicated for patients with unresectable liver cancer — primary as well as metastatic. It's also similar to SIRT in delivery. The difference is in the type of material being injected into the tumor. Chemoembolization micro beads contain a chemo drug (Doxorubicin, Cisplatin, Mitomycin, or Irinotecan); SIRT beads contain a radiopharma- ceutical. In addition to the chemo drug, chemoembolization beads may include an ischemia-producing material to close off the tumor's blood supply. "We use chemoembolization where the lesions are localized and systemic chemotherapy has not worked, as indicated by the lesions continuing to grow," Dr. Kar explains. "The goal is to help the patient along to remission and prolong his or her life." And because chemoembolization treats the liver directly, the systemic effects are reduced, which improves the patient's quality of life. Tumor Ablation In patients with tumors in the liver, kidneys and lungs that are inoperable via conventional means, or the risk of surgery or anesthesia outweighs the benefits, image guided ablations may be more appropriate. Aultman offers three different types of tumor ablation: radiofrequency and microwave — both of which utilize heat to ablate tumors — and cryotherapy, which freezes the tumor cells. The procedure involves passing a probe through the skin into the tumor to heat or freeze the tumor and destroy it. The location of the tumor determines the type of ablation. "Once a patient is referred, our physicians get all of the testing done to determine which type of treatment the patient is best suited for," says Donato. "Our doctors work closely with each patient's oncologist and other referring physicians throughout the entire process — up until that episode of care has been completed. And then the patient is sent back to the referring physician to continue their care." Trans-jugular Liver Biopsy and TIPS In addition to interventions for cancer, Aultman offers other advanced liver-based procedures, such as trans-jugular liver biopsy, trans-jugular intrahepatic portosystemic shunt place- ment (TIPS), and balloon-occluded retrograde transvenous obliteration (BRTO). "Trans-jugular liver biopsy is the preferred method of liver biopsy for patients who have a high risk of bleeding from liver disease," Dr. Kar says. "Usually the gastroenterologists order this when they want to diagnose the degree of cirrhosis in a patient or, if a patient has hepatitis C, they order it to get a better idea of which medication will work best." He e x pla i n s t h at pat ient s m ay b e c i r rhot ic f rom hepatitis B or C, or from a history of alcoholism, or from liver disease that has progressed to cirrhosis from chronic inflammation in the liver. Because these patients' livers are not functioning correctly, they will have increased pressure in the portal vein system resulting in fluid accumulation in the abdomen. When frequent tapping is required to drain the fluid, TIPS is an option. One of the most advanced interventional oncology treatments now offered at Aultman Hospital is Selective Internal Radiation Therapy (SIRT), which provides targeted radiation to unresectable metastatic liver tumors. SIRT involves image-guided placement of a transfemoral microcatheter in the hepatic artery, through which Y-90 microscopic beads are then selectively implanted in the microvascular arterial supply of the tumor to kill cancer cells. ILLUSTRATION COURTESY OF SIRTEX, SIRTEX.COM 1 8 | Cleveland/Akron/Canton MD NEWS ■ M D N E W S . CO M ■ N OV E M B E R / D E C E M B E R 2 0 1 5 SPECI A L FE AT UR E

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Cleveland-Akron-Canton - November/December 2015